Table 2 Treatment details and results
Number | % | |
|---|---|---|
Radiotherapy dose (Gy) | ||
Median (range) | (50.4-54) 51.12 | |
Patients receiving 50.4 Gy | 16 | 80 |
Chemotherapy | ||
Capecitabine | 13 | 65 |
UFT | 5 | 25 |
CI 5FU | 2 | 10 |
Interval between RCT and surgery (weeks) | ||
Median (range) | 8.7 (6.6 – 21.11) | |
Surgery | ||
LAR | 16 | 80 |
APR2 | 4 | 20 |
Surgical margins | ||
R0 | 19 | 95 |
R1 | 1 | 5 |
Pathological TNM stage | ||
0 | 4 | 20 |
I | 5 | 25 |
II | 3 | 15 |
III | 7 | 35 |
IV | 1 | 5 |
Tumor regression grade | ||
I | 4 | 20 |
II | 2 | 10 |
III | 9 | 45 |
IV | 5 | 25 |
V | 0 | 0 |